Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015672
Disease: Fatigue
Fatigue
0.030 GeneticVariation phenotype BEFREE The primary outcome is the prevalence of persistent symptoms after treatment, assessed by questionnaires online focusing on fatigue (CIS, subscale fatigue severity), pain (SF-36, subscale pain) and neurocognitive dysfunction (CFQ). 30987580 2019
CUI: C0015672
Disease: Fatigue
Fatigue
0.030 Biomarker phenotype BEFREE Severe fatigue (CIS-Fatigue ≥ 36 points) was detected in 62.6% of patients. 30477110 2018
CUI: C0015672
Disease: Fatigue
Fatigue
0.030 GeneticVariation phenotype BEFREE While the CIS-20 total score and subscale scores (including subjective experience of fatigue) were similar between patients with FMF and those with other chronic rheumatic diseases (p > .05); both groups had significantly higher scores when compared with healthy subjects (p < .05). 29322855 2018